NCT04710446

Brief Summary

the investigators aimed to analyzed data for hospitalized MI patients with normal ECG.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2018

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2018

Completed
2.9 years until next milestone

First Submitted

Initial submission to the registry

December 2, 2020

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 14, 2021

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2023

Completed
Last Updated

August 12, 2022

Status Verified

August 1, 2022

Enrollment Period

5 years

First QC Date

December 2, 2020

Last Update Submit

August 11, 2022

Conditions

Non-ST Elevated Myocardial InfarctionElectrocardiography

Keywords

Clinical CharacteristicsTreatmentsOutcomesnormal ECG

Outcome Measures

Primary Outcomes (2)

  • MACE within 2 weeks

    Major Adverse Cardiovascular Events within2 weeks

    within 2 weeks

  • MACE within 1 year

    Major Adverse Cardiovascular Events in-hospital within 1 year

    within 1 year

Study Arms (5)

NSTEMI Patients presenting with normal ECG

NSTEMI Patients presenting with normal ECG

NSTEMI Patients presenting with isolated T wave inversion

NSTEMI Patients presenting with isolated T wave inversion

NSTEMI Patients presenting with transient ST-segment elevation

NSTEMI Patients presenting with transient ST-segment elevation

NSTEMI Patients presenting with resting U wave inversion

NSTEMI Patients presenting with resting U wave inversion

NSTEMI Patients presenting with low QRS voltage

NSTEMI Patients presenting with low QRS voltage

Eligibility Criteria

Age20 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

NSTEMI Patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Henan province people's hospital

Zhengzhou, Henan, China

RECRUITING

MeSH Terms

Conditions

Non-ST Elevated Myocardial Infarction

Condition Hierarchy (Ancestors)

Myocardial InfarctionMyocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosis

Study Officials

  • yansheng Huang

    Henan Provincial People's Hospital

    STUDY DIRECTOR

Central Study Contacts

qiongya Guo

CONTACT

18838067197gqy19870203@163.com

minghu Zhao

CONTACT

13603996609634851967@qq.com

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 2, 2020

First Posted

January 14, 2021

Study Start

January 1, 2018

Primary Completion

January 1, 2023

Study Completion

January 1, 2023

Last Updated

August 12, 2022

Record last verified: 2022-08

Locations

CN(1)